The new era of cellular immunotherapies has provided state-of-the-art and efficient strategies for the prevention and treatment of cancer and infectious diseases. Cellular immunotherapies are at the forefront of innovative medical care, including adoptive T cell therapies, cancer vaccines, NK cell therapies, and immune checkpoint inhibitors. The focus of this review is on cellular immunotherapies and their application in the lung, as respiratory diseases remain one of the main causes of death worldwide. The ongoing global pandemic has shed a new light on respiratory viruses, with a key area of concern being how to combat and control their infections. The focus of cellular immunotherapies has largely been on treating cancer and has had major successes in the past few years. However, recent preclinical and clinical studies using these immunotherapies for respiratory viral infections demonstrate promising potential. Therefore, in this review we explore the use of multiple cellular immunotherapies in treating viral respiratory infections, along with investigating several routes of administration with an emphasis on inhaled immunotherapies.
【저자키워드】 antibody, NK cell, respiratory viruses, T cell, Respiratory disease, inhalation, Cellular Immunotherapy, DC vaccine, 【초록키워드】 Treatment, Diseases, Vaccines, Immunotherapy, Cancer, lung, global pandemic, infections, death, Inhaled, Care, respiratory viral infection, Therapies, cellular, clinical study, administration, Immune checkpoint inhibitors, immunotherapies, viral respiratory infections, provided, cause,